Suzhou Highfine Biotech Co., Ltd. (SHE:301393)

Suzhou Highfine Biotech Revenue

Suzhou Highfine Biotech had revenue of 135.21M CNY in the quarter ending March 31, 2025, with 48.21% growth. This brings the company's revenue in the last twelve months to 495.86M, up 39.75% year-over-year. In the year 2024, Suzhou Highfine Biotech had annual revenue of 451.87M with 16.22% growth.

• Revenue (ttm): 495.86M
• Revenue Growth: +39.75%
• P/S Ratio: 12.70
• Revenue / Employee: 1.16M
• Employees: 428
• Market Cap: 6.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	451.87M	63.08M	16.22%
Dec 31, 2023	388.79M	-58.66M	-13.11%
Jan 1, 2023	447.46M	78.02M	21.12%
Dec 31, 2021	369.44M	87.09M	30.85%
Dec 31, 2020	282.35M	91.10M	47.63%